- Home
- JNVR vs LSBPW Comparison
JNVR vs LSBPW Comparison
Compare JNVR & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- LSBPW
- Stock Information
- Founded
- JNVR 2018
- LSBPW N/A
- Country
- JNVR United States
- LSBPW China
- Employees
- JNVR N/A
- LSBPW 758
- Industry
- JNVR Finance: Consumer Services
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- LSBPW Health Care
- Exchange
- JNVR Nasdaq
- LSBPW Nasdaq
- Market Cap
- JNVR N/A
- LSBPW N/A
- IPO Year
- JNVR 2023
- LSBPW N/A
- Fundamental
- Price
- JNVR $0.55
- LSBPW $0.07
- Analyst Decision
- JNVR
- LSBPW
- Analyst Count
- JNVR 0
- LSBPW 0
- Target Price
- JNVR N/A
- LSBPW N/A
- AVG Volume (30 Days)
- JNVR 21.7K
- LSBPW N/A
- Earning Date
- JNVR 11-12-2024
- LSBPW N/A
- Dividend Yield
- JNVR N/A
- LSBPW N/A
- EPS Growth
- JNVR N/A
- LSBPW N/A
- EPS
- JNVR N/A
- LSBPW N/A
- Revenue
- JNVR $1,786,085.00
- LSBPW N/A
- Revenue This Year
- JNVR N/A
- LSBPW N/A
- Revenue Next Year
- JNVR N/A
- LSBPW N/A
- P/E Ratio
- JNVR N/A
- LSBPW N/A
- Revenue Growth
- JNVR N/A
- LSBPW N/A
- 52 Week Low
- JNVR $0.42
- LSBPW N/A
- 52 Week High
- JNVR $1.84
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- JNVR 49.64
- LSBPW N/A
- Support Level
- JNVR $0.49
- LSBPW N/A
- Resistance Level
- JNVR $0.62
- LSBPW N/A
- Average True Range (ATR)
- JNVR 0.06
- LSBPW 0.00
- MACD
- JNVR -0.00
- LSBPW 0.00
- Stochastic Oscillator
- JNVR 58.69
- LSBPW 0.00
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.